AdaptHealth Corp. (NASDAQ:AHCO) Receives Consensus Rating of “Moderate Buy” from Analysts

AdaptHealth Corp. (NASDAQ:AHCO) has been given an average rating of “Moderate Buy” by the six analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $13.25.

Several equities research analysts have recently issued reports on AHCO shares. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $13.00 price target on shares of AdaptHealth in a research report on Wednesday, February 25th. Wall Street Zen lowered AdaptHealth from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. Leerink Partners reduced their price objective on AdaptHealth from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Thursday, February 26th. Weiss Ratings lowered shares of AdaptHealth from a “hold (c-)” rating to a “sell (d)” rating in a research report on Wednesday, February 25th. Finally, Zacks Research upgraded shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st.

Insiders Place Their Bets

In other news, major shareholder Richard M. Cashin, Jr. purchased 689,336 shares of the stock in a transaction that occurred on Thursday, March 12th. The shares were purchased at an average cost of $9.73 per share, for a total transaction of $6,707,239.28. Following the completion of the purchase, the insider directly owned 15,864,871 shares of the company’s stock, valued at approximately $154,365,194.83. The trade was a 4.54% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders bought 2,046,691 shares of company stock worth $19,914,303 over the last 90 days. 1.55% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Rockefeller Capital Management L.P. increased its holdings in AdaptHealth by 433.0% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock valued at $26,000 after buying an additional 2,100 shares during the period. FNY Investment Advisers LLC bought a new stake in AdaptHealth in the third quarter valued at about $35,000. PNC Financial Services Group Inc. raised its position in AdaptHealth by 22.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after purchasing an additional 1,279 shares in the last quarter. Tower Research Capital LLC TRC lifted its stake in AdaptHealth by 318.0% during the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after purchasing an additional 7,297 shares during the period. Finally, Tidal Investments LLC acquired a new stake in AdaptHealth during the second quarter valued at approximately $96,000. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Stock Down 1.7%

AHCO stock opened at $9.91 on Friday. AdaptHealth has a 1-year low of $7.11 and a 1-year high of $11.17. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.02 and a quick ratio of 0.81. The firm has a fifty day moving average price of $10.10 and a two-hundred day moving average price of $9.71. The firm has a market cap of $1.35 billion, a price-to-earnings ratio of -18.02, a PEG ratio of 1.14 and a beta of 1.76.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings data on Tuesday, February 24th. The company reported ($0.76) earnings per share for the quarter, missing analysts’ consensus estimates of $0.34 by ($1.10). AdaptHealth had a positive return on equity of 3.42% and a negative net margin of 2.18%.The firm had revenue of $846.29 million during the quarter, compared to analyst estimates of $832.51 million. During the same quarter in the previous year, the firm posted $0.34 earnings per share. AdaptHealth’s quarterly revenue was down 1.2% compared to the same quarter last year. Research analysts predict that AdaptHealth will post 0.88 EPS for the current year.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.